Despite a positive trend, the adjusted mean change from baseline in overall satisfaction was not significantly higher in the empagliflozin arm than in the glimepiride arm at the final visit.
← all excerpts
Treatment satisfaction in type 2 diabetes patients taking empagliflozin compared with patients taking glimepiride.
1
—
—